Drug profile · INN
fingolimod hydrochloride
FINGOLIMOD HYDROCHLORIDE
fingolimod hydrochloride (FINGOLIMOD HYDROCHLORIDE) is a sphingosine 1-phosphate receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — fingolimod hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.89
Quick answer
fingolimod hydrochloride (FINGOLIMOD HYDROCHLORIDE) is a sphingosine 1-phosphate receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Sphingosine 1-phosphate receptor agonist
Primary target: Sphingosine 1-phosphate receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is fingolimod hydrochloride?
fingolimod hydrochloride (FINGOLIMOD HYDROCHLORIDE) is a sphingosine 1-phosphate receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fingolimod hydrochloride?
FINGOLIMOD HYDROCHLORIDE is a marketed brand name for fingolimod hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fingolimod hydrochloride?
fingolimod hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.